IAH1 and neoplasm: However, the use of ALK inhibitors without sufficient consideration is controversial, because IAH1-ALK is a novel ALK fusion gene, and the ALK signal was negative as determined by the immunostaining of lymph node metastasis samples, suggesting primary tumor heterogeneity (Figure 2F).